SELECT-SLE: Biomarker-Guided CAR-T Target Selection for Refractory Lupus
Clinical trial NCT07523542 · RECRUITING
Trial details
- NCT number
- NCT07523542
- Sponsor
- Beijing Biotech
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-02
- Primary completion
- 2027-03-14
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.